News
The Loveland Creative District is accepting proposals for Frames on 4th, an opportunity for creatives to design selfie frames for visitors to use in the Heart Improvement Construction Zone. The ...
4d
Ideal Home on MSNMy editor swears by this framing trick to make any wall art look more expensive – I’m taking her advice on board, and so should youHaving art hung up on your walls instantly elevates a space and makes it feel more personable, cosy and stylish. But while ...
Hosted on MSN15d
Turn Dollar Tree poster board & moss into THIS! - MSNIn this creative DIY tutorial, discover how to transform simple Dollar Tree poster board and moss into stunning home décor pieces that will impress everyone! Follow along as we guide you through ...
On the eve of the 2025 NBA Draft, let's run down the top prospects in this year's draft class with a final Big Board.
SAN JOSE DE BUENAVISTA, Antique – Provincial Board Member Karmila Rose Dimamay is repurposing her campaign tarpaulin posters into tote bags, which she distributes at markets to lessen the use of ...
Gov. Glenn Youngkin has voiced disapproval over the Arlington County Board's decision this week to limit police interactions with U.S. Immigration and Customs Enforcement. The County Board voted ...
The poster will showcase the design and ongoing progress of its Phase 1 study of CID-078 (NCT06577987), a first-in-class, oral macrocycle cyclin A/B RxL inhibitor.
SOUTH SAN FRANCISCO, Calif.-- (BUSINESS WIRE)-- #ASCO2025 --Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat cancers, today announced ...
The Chenango County Traffic Safety Board will use winning entries to educate the public about pedestrian and bicycle safety in its Pedestrian and Bicycle Safety campaign.
The company will also present data on ONO-4578, an investigational EP4 antagonist, for the treatment of locally advanced resectable rectal cancer, during a poster presentation.
PARIS-- (BUSINESS WIRE)--Egle Therapeutics, a clinical-stage biotechnology company developing therapies targeting regulatory T cells (Tregs) for immuno-oncology and autoimmune diseases, will present ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results